GIM
NEO icon

Glenmede Investment Management’s NeoGenomics NEO Stock Holding History

Glenmede Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12.1M Buy
1,561,790
+484,005
+45% +$3.39M 0.06% 309
2025
Q2 		$7.88M Buy
+1,077,785
New +$8.7M 0.04% 390

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Glenmede Investment Management's NEO Position: Q3 2025 in Review

Glenmede Investment Management increased its NeoGenomics (NEO) stake by 45% in Q3 2025, buying an estimated $3.39M and bringing the position to 1,561,790 shares worth $12.1M. The position accounts for 0.06% of the portfolio, ranked #309.

Glenmede Investment Management first reported a position in NEO in Q2 2025 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Glenmede Investment Management held 1,561,790 shares of NeoGenomics worth $12.1M as of Q3 2025.
  • Glenmede Investment Management bought 484,005 NeoGenomics shares in Q3 2025, an estimated $3.39M.
  • NeoGenomics made up 0.06% of Glenmede Investment Management's portfolio in Q3 2025, its #309 holding.
  • Glenmede Investment Management first reported a position in NeoGenomics in Q2 2025 and has held it in 2 quarters since.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.